Quality

The focus of quality improvement in healthcare is to bolster performance and processes related to diagnostic and therapeutic procedures. Leaders in this space also ensure the proper selection of imaging exams and procedures, and monitor the safety of services, among other duties. Reimbursement programs such as the Merit-based Incentive Payment System (MIPS) utilize financial incentives to improve quality. This also includes setting and maintaining care quality initiatives, such as the requirements set by the Joint Commission.

Mortality rises in hours if physicians don’t follow sepsis protocol

Physicians have resisted stricter guidelines on early screening and treatment of sepsis, arguing there isn’t enough evidence the extra effort benefits patients—which is precisely what a new study of New York hospitals provides.

Thumbnail

Prescribing more opioids won’t affect HCAHPS scores

University of Michigan researchers found no association between prescribing more opioid painkillers to postoperative patients and higher pain management scores on patient satisfaction surveys, undercutting physicians’ perceptions that they’ve been incentivized to prescribe the potentially addictive drugs.  

Thumbnail

Joint Commission: No social media posts about nursing home residents

Posting about nursing home residents on Facebook, Snapchat or other forms of social media “violates more codes than you could ever imagine,” according to the Joint Commission, which advised facilities to draft their own social media policies.

Thumbnail

CMS: More than 800,000 clinicians will be exempt from MIPS

CMS had expected more than half of Medicare providers to be exempt from the new Merit-based Incentive Payment System (MIPS) in its first year. That ended up being a low estimate, as CMS said 65 percent have been notified they won’t be participating in MIPS for 2017.

Thumbnail

Higher priced practices don’t necessarily deliver higher value care

The claims that larger, higher priced providers outperform lower-priced practices on quality and efficiency of care don’t hold up, according to a new study from Harvard Medical School researchers.

Drug-resistant fungus ‘acting like a superbug’ in U.S. hospitals

A so-called “superfungus” resistant to the typical antifungal medications is showing up in U.S. hospitals, particularly in New York and New Jersey.

U.S. hospitals still seeing 1,500 malaria cases a year

The transmission of malaria among the general population in the U.S. hasn’t been an issue for nearly 60 years—but as NPR reports, it’s a different story in hospitals, where nearly 1,500 cases are seen each year involving people who have been traveling abroad.

Thumbnail

FAH’s Chip Kahn: We need uniform quality measures when possible

Chip Kahn, president and CEO of the Federation of American Hospitals, gave a harsh assessment of current quality measurement processes at a Health Affairs forum in Washington, D.C. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.